- Home
- CARE vs FDMT Comparison
CARE vs FDMT Comparison
Compare CARE & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CARE | FDMT |
|---|---|---|
| Founded | 1974 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 438.9M | 431.4M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CARE | FDMT |
|---|---|---|
| Price | $20.07 | $8.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $34.29 |
| AVG Volume (30 Days) | 101.5K | ★ 751.9K |
| Earning Date | 01-23-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 118.48 | N/A |
| EPS | ★ 1.36 | N/A |
| Revenue | ★ $154,517,000.00 | $120,000.00 |
| Revenue This Year | $11.32 | $21,227.03 |
| Revenue Next Year | $15.99 | $161.87 |
| P/E Ratio | $14.84 | ★ N/A |
| Revenue Growth | 20.24 | ★ 605.88 |
| 52 Week Low | $13.61 | $2.24 |
| 52 Week High | $21.46 | $12.34 |
Technical Indicators
Market Signals| Indicator | CARE | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 52.88 |
| Support Level | $19.69 | $7.77 |
| Resistance Level | $21.46 | $8.25 |
| Average True Range (ATR) | 0.58 | 0.53 |
| MACD | -0.06 | 0.19 |
| Stochastic Oscillator | 25.84 | 81.47 |
Price Performance
Historical ComparisonAbout CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.